Massachusetts Financial Services Co. MA lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,446,660 shares of the company's stock after selling 22,358 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.06% of Procter & Gamble worth $207,321,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at about $25,000. Maseco LLP acquired a new stake in shares of Procter & Gamble in the 4th quarter valued at about $28,000. Saranac Partners Ltd acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at about $30,000. Corundum Trust Company INC acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at about $32,000. Finally, Caitlin John LLC acquired a new stake in shares of Procter & Gamble in the 3rd quarter valued at about $34,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Insider Buying and Selling at Procter & Gamble
In related news, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the transaction, the chairman owned 319,385 shares in the company, valued at approximately $51,884,093.25. This trade represents a 33.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Marc S. Pritchard sold 95,903 shares of Procter & Gamble stock in a transaction dated Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the transaction, the insider owned 182,607 shares of the company's stock, valued at $27,601,048.05. The trade was a 34.43% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 348,618 shares of company stock valued at $55,462,643 in the last three months. Corporate insiders own 0.20% of the company's stock.
Analysts Set New Price Targets
PG has been the topic of several recent research reports. Barclays set a $155.00 price target on Procter & Gamble in a research note on Friday, January 16th. BNP Paribas Exane decreased their price objective on Procter & Gamble from $172.00 to $164.00 and set an "outperform" rating for the company in a report on Friday, January 16th. TD Cowen decreased their price objective on Procter & Gamble from $156.00 to $142.00 and set a "hold" rating for the company in a report on Wednesday, April 1st. JPMorgan Chase & Co. upgraded Procter & Gamble from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $157.00 to $165.00 in a report on Friday, January 23rd. Finally, The Goldman Sachs Group decreased their price objective on Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a report on Wednesday, April 8th. Twelve equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $163.89.
Check Out Our Latest Stock Analysis on PG
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
Procter & Gamble Price Performance
Shares of NYSE PG opened at $145.17 on Monday. The stock has a market capitalization of $337.37 billion, a price-to-earnings ratio of 21.51, a PEG ratio of 5.11 and a beta of 0.41. The business has a 50-day moving average of $153.04 and a 200-day moving average of $149.21. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $171.65.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The business had revenue of $22.21 billion during the quarter, compared to analysts' expectations of $22.36 billion. During the same quarter last year, the company posted $1.88 earnings per share. Procter & Gamble's quarterly revenue was up 1.5% on a year-over-year basis. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were issued a dividend of $1.0568 per share. The ex-dividend date was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble's dividend payout ratio (DPR) is presently 62.52%.
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.